Incidence and management of prostatic urethra recurrence in a cohort of 21 patients who received BCG induction for non-muscle invasive bladder cancer

•The Natural history of Prostatic Urethra recurrences after BCG Induction has not been well described in the literature.•Patients with Prostatic Urethra recurrences have a high-risk disease phenotype.•Radical Cystoprostatectomy is often first line treatment for these patients.•Conservative managemen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Urologic oncology 2024-09, Vol.42 (9), p.290.e11-290.e16
Hauptverfasser:	Ingram, Justin W., Chung, Rainjade, Laplaca, Caroline, McKiernan, James M., Lenis, Andrew T., Anderson, Christopher B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvants, Immunologic - therapeutic use Aged Aged, 80 and over BCG Vaccine - administration & dosage BCG Vaccine - therapeutic use Carcinoma, Transitional Cell - pathology Carcinoma, Transitional Cell - therapy Cohort Studies Conservative treatment Cystectomy Humans Incidence Intravesical therapy Male Middle Aged Neoplasm Invasiveness Neoplasm recurrence Neoplasm Recurrence, Local Non-Muscle Invasive Bladder Neoplasms Prostatic Neoplasms - pathology Prostatic Neoplasms - therapy Retrospective Studies Transitional Cell carcinoma Urethral neoplasms Urethral Neoplasms - pathology Urethral Neoplasms - therapy Urinary bladder neoplasms Urinary Bladder Neoplasms - pathology Urinary Bladder Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!